Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer
2024 · BMC Cancer · 83 citations
https://doi.org/10.1186/s12885-023-11764-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
113
Citations
3
h-index
3
i10-index
Wenqian Lei is an academic researcher from Qujiang People's Hospital. The author has contributed to research in topics: Lung Cancer Research Studies & HER2/EGFR in Cancer Research & Inflammatory Biomarkers in Disease Prognosis. The author has an h-index of 3, co-authored 7 publications.
https://doi.org/10.1186/s12885-023-11764-8
https://doi.org/10.1038/s41598-024-66813-4
Click to start Chat